Skip to main content

Table 5 Antimicrobial resistance profiles of A. baumannii and P. aeruginosa isolates from participants presumptive for nosocomial infection at FHRH, Bahir Dar, Northwest Ethiopia, April to July, 2018

From: Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study

Antimicrobials

A.baumannii

P.aeruginosa

Total

# T

R %

# T

R %

# T

R%

Ampicillin

9

9 (100)

11

11 (100)

20

20 (100)

Amoxicillin-clavulanic acid

9

8 (88.9)

11

11 (100)

20

19 (95)

Piperacillin

9

9 (100)

11

11 (100)

20

20 (100)

Cefotaxime

9

8 (88.9)

11

11 (100)

20

19 (95)

Ceftriaxone

9

8 (88.9)

11

11 (100)

20

19 (95)

Ceftazidime

9

7 (77.8)

11

7 (63.6)

20

14 (70)

Ciprofloxacin

9

4 (44.5)

11

4 (36.4)

20

8 (40)

Gentamicin

9

8 (88.9)

11

6 (54.5)

20

14 (70)

Meropenem

9

3 (33.3)

11

5 (45.5)

20

8 (40)

Tetracycline

9

7 (77.8)

11

10 (90.9)

20

17 (85)

Sulphamethoxazole - Trimethoprim

9

6 (66.7)

11

11 (100)

20

17 (85)

Total

99

77 (77.8)

121

98 (80.99)

220

175 (79.5)

  1. #T: Number of isolates tested, R%: Percentage of resistant isolates